or
Bookmark and Share
Adrenocorticotropin-lipotropin precursor gene
   
Document Number
US Patent 4322499
Issued Date
March 30, 1982
Link
Inventors
Baxter; John D. (San Francisco, CA)
Roberts; James L. (San Francisco, CA)
Seeburg; Peter H. (San Francisco, CA)
Goodman; Howard M. (San Francisco, CA)
Map
Abstract
A technique suitable for cloning a cDNA having a base sequence coding for the ACTH/LPH precursor is disclosed. The invention is exemplified by the cloning of a cDNA fragment comprising a base sequence coding for the endorphin region. The fragment, hereinafter termed the endorphin gene cDNA sequence, was obtained from cultured mouse pituitary tumor cells known to produce the ACTH/LPH precursor protein.
Drawing
Adrenocorticotropin-lipotropin precursor gene - US Patent 4322499 Drawing
Drawing from US Patent 4322499
Tags:
Description:
Amusing 0%
Clever 0%
Complex 0%
Efficient 0%
Historic 0%
Important 0%
Innovative 0%
Interesting 0%
Practical 0%
Simple 0%
Number of Claims:
8
Comments:
no comments yet
Published
March 30, 1982
Application Number
06/972,430
Filed
December 22, 1978
US Classification
435/252.33   435/252.3 435/320.1 435/69.1 435/69.4 435/91.41 536/23.51 930/70 930/80
Int'l Classification
C07K   14/435   (20060101)   C07K   14/665   (20060101)  
USPTO Field of Search
435/172   435/253   435/317   435/255  
Related Patents
4745051 - Method for producing a recombinant baculovirus expression vector - Owned by The Texas A&M University System (College Station, TX)

A method for producing a recombinant baculovirus expression vector, capable of expression of a selected gene in a host insect cell, is disclosed. The preferred method involves cleaving baculovirus DNA to produce a DNA fragment comprising a polyhedrin gene or portion thereof, including a polyhedrin promoter. A recombinant shuttle vector is prepared by inserting said DNA fragment into a cloning vehicle and thereafter inserting a selected gene into the thus modified cloning vehicle such that it is under the transcriptional control of the polyhedrin promoter. The recombinant shuttle vector is contacted with a baculovirus DNA so as to effect recombination and incorporation of the selected gene into the baculovirus genome.

4719180 - Synthetic urogastrone gene, corresponding plasmid recombinants, transformed cells, production thereof and urgastrone expression - Owned by G. D. Searle & Co. (Skokie, IL)

A synthetic gene characterised in that it codes for the expression of urogastrone or a sub-unit thereof is disclosed. The production thereof by the assembly and ligation of a number of nucleotide blocks is also disclosed, as are corresponding plasmid recombinants, transformed cells and the production thereof. The expression of urogastrone is further disclosed. Urogastrone is a polypeptide hormore (protein) which may be isolated in small amounts from human urine. It has an application in the treatment of ulcers and in the promotion of wound healing. The present invention provides a more viable commercial production.

4879236 - Method for producing a recombinant baculovirus expression vector - Owned by The Texas A&M University System (College Station, TX) [*] Notice:The portion of the term of this patent subsequent to May 17, 2005 has been disclaimed.

A method for producng a recombinant baculovirus expression vector, capable of expressing a selected gene in a host insect cell, is disclosed. The method involves cleaving baculovirus DNA to produce a DNA fragment comprising a polyhedrin gene or portion thereof, including a polyhedrin promoter. A recombinant transfer vector is prepared by inserting said DNA fragment into a cloning vehicle and thereafter inserting a selected gene into the thus modified cloning vehicle such that it is under the transcriptional control of the polyhedrin promoter. The recombinant transfer vector is contacted with a baculovirus DNA so as to effect recombination and incorporation of the selected gene into the baculovirus genome. The resultant recombinant baculovirus is then used to infect susceptible insects or cultured insect cells and the protein product from the incorporated selected gene is produced from the infection.

5075224 - Prepro-LHRH C-terminal peptide DNA - Owned by Genentech, Inc. (South San Francisco, CA)

DNA encoding a novel polypeptide hormone, designated CTP, has been identified in the human genome. CTP is expressed as a fusion protein (proLHRH) with luteinizing hormone releasing hormone (LHRH), and is post-translationally processed to CTP and LHRH. CTP, its derivatives, and its fusions, including proLHRH, are useful in therapy and diagnostics.

4966840 - Stable high copy number plasmids - Owned by Cetus Corporation (Emeryville, CA) [*] Notice:The portion of the term of this patent subsequent to December 23, 2003 has been disclaimed.

DNA plasmids are described which are selected mutants in which an altered repressor gene leads to high copy number replication. Elements in the plasmids are modified in such a way that readthrough expression of heterologous DNA inserted in the plasmid will not continue into the replication primer strand. Deletions resulting from interference with replication primer strand transcription are thereby avoided.

Claims
Description
About| FAQs| Terms & Disclaimer| Link to Us| Contact Us